Patent details

Basic Information

Publication number:

EP2152917

PCT Application Number:

PCT/US/2008/064027

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087558094

PCT Publication Number:

WO/2008/144599

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS

French Title of Invention:

MARQUEURS GÉNÉTIQUES D'EFFICACITÉ DE L'ILOPÉRIDONE DANS LE TRAITEMENT DE SYMPTÔMES PSYCHOTIQUES

German Title of Invention:

GENETISCHE MARKER FÜR DIE WIRKUNG VON ILOPERIDON BEI DER BEHANDLUNG PSYCHOTISCHER SYMPTOME

SPC Number:

Dates

Filing date:

17/05/2008

Grant date:

23/03/2016

EP Publication Date:

23/03/2016

PCT Publication Date:

27/11/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/02/2010

EP B1 Publication Date:

23/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/05/2016

Expiration date:

17/05/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/05/2008

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

9605 Medical Center Drive, Suite 300, Rockville NY 20850, United States (US)

Inventor

1

Name:

POLYMEROPOULOS Mihael, H.

Address:

United States (US)

2

Name:

LICAMELE Louis

Address:

United States (US)

3

Name:

VOLPI Simona

Address:

United States (US)

4

Name:

LAVEDAN Christian

Address:

United States (US)

Priority

Priority Number:

939033 P

Priority Date:

18/05/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages